Elite Pharmaceuticals Inc (ELTP): End of year Catalyst : Isradipine 2....

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Elite Pharmaceuticals Inc (ELTP)

Reply Private New

Keep Last Read

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	188
Posts	28647
Boards Moderated	1
Alias Born	08/29/2012

Re: None

Friday, 09/19/2014 10:26:05 PM

Friday, September 19, 2014 10:26:05 PM

End of year Catalyst :

Isradipine 2.5 mg and 5.0 mg capsules Approval
Isradipine 2.5 mg and 5.0 mg capsules Launch
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Approval
Dantrolene Sodium 25 mg, 50 mg and 100 mg capsules Launch
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Approval
Loxapine 5mg, 10mg, 25 mg, 50 mg capsules Launch
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Approval
Hydroxyzine HCI 10 mg, 25 mg, 50 mg tablets Launch
ELI-201 Pivotal BE Results
ELI-202 Pivotal BE Results
ELI-200 In Vitro Lab Abuse Study Results
ELI-200 In Vivo Human Abuse Liability Results
ELI-202 In Vitro Lab Abuse Study Results
ELI-202 In Vivo Human Abuse Liability Results
ELI-203 Pivotal BE Study Initiation
Microcapsule Patent
Fast Track meeting with FDA
Partnership announcement(s)
November 2014 Conference Call
December ELI-200 NDA ART FDA Filing
Buyout Announcement

You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him

Keep Last Read

Replies (3) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ELTP News

Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM

More ELTP News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow